Lantheus Holdings, Inc vs. Myriad Genetics Inc
Lantheus Holdings, Inc (LNTH) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| LNTH | MYGN | |
|---|---|---|
| Market Cap | $6.56 billion | $305.12 million |
| Revenue (TTM) | $1.56 billion | $806.60 million |
| Net Income (TTM) | $275.31 million | $-112,600,000 |
LNTH leads on 3 of 3 size & scale factors.
Valuation
| LNTH | MYGN | |
|---|---|---|
| P/E Ratio | 24.27 | — |
| Price / Book | 5.00 | 1.00 |
| Price / Sales | 4.21 | 0.38 |
MYGN leads on 2 of 2 valuation factors.
Profitability
| LNTH | MYGN | |
|---|---|---|
| Net Margin | 17.69% | -13.96% |
| Return on Equity | 20.99% | -37.05% |
LNTH leads on 2 of 2 profitability factors.
Risk & Sentiment
| LNTH | MYGN | |
|---|---|---|
| Short Interest | 0.72% | 13.76% |
LNTH leads on 1 of 1 risk & sentiment factors.
Dig deeper: LNTH overview, LNTH financials, MYGN overview, MYGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.